Literature DB >> 15371878

Autocrine over expression of fibronectin by human transitional carcinoma cells impairs bacillus Calmette-Guerin adherence and signaling.

Guangjian Zhang1, Fanghong Chen, Yong Xu, Yanli Cao, Scott Crist, Amy McKerrow, Yoshiki Iwamoto, William A See.   

Abstract

PURPOSE: Bacillus Calmette-Guerin (BCG) binds to the tumor cell as a result of mycobacterial receptors for fibronectin (FN). Cell surface bound FN serves as a bridge through which BCG attaches to the tumor cell. Despite the importance of FN studies have demonstrated an idiosyncratic decrease in BCG adherence in response to exogenous FN. We evaluated the effect of exogenous and autocrine FN on the ability of BCG to adhere to the tumor cell surface and initiate cellular signaling.
MATERIALS AND METHODS: BCG adherence to parental 253J and FN over expressing 253JTGFbeta1-8 cells as well as to the intrinsic FN expressing cell line 647V was quantified using green fluorescent protein-BCG. Experiments were performed to assess the effect of FN on BCG initiated signal transduction through nuclear factor kappaB and AP1. Finally, the integrity of the BCG activated signaling pathway in transforming growth factor-beta1/FN over expressors was assessed using antibody mediated cross-linking of the FN receptor.
RESULTS: BCG adherence was decreased in cell lines with high autocrine expression of FN. Exogenous FN prevented BCG induced transactivation of nuclear factor kappaB and AP1 reporter constructs. No BCG stimulated signaling to these reporters could be detected in FN over expressing 253J cells. NonFN dependent alpha5beta1 cross-linking initiated signal transduction in FN over expressing cells.
CONCLUSIONS: We propose that by saturating cellular and BCG receptors excess FN expression decreases the ability of cellular or mycobacterial bound FN to bind vacant receptors on BCG or on the cell. Excess FN inhibits BCG adherence and BCG initiated signal transduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371878     DOI: 10.1097/01.ju.0000140193.95528.91

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

2.  BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking.

Authors:  Fanghong Chen; Guangjian Zhang; Yoshiki Iwamoto; William A See
Journal:  BMC Urol       Date:  2005-05-12       Impact factor: 2.264

3.  Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins.

Authors:  Marcia R Saban; Helen L Hellmich; Cindy Simpson; Carole A Davis; Mark L Lang; Michael A Ihnat; Michael A O'Donnell; Xue-Ru Wu; Ricardo Saban
Journal:  BMC Cancer       Date:  2007-11-02       Impact factor: 4.430

4.  Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

Authors:  Marcia R Saban; Cindy Simpson; Carole Davis; Gemma Wallis; Nicholas Knowlton; Mark Barton Frank; Michael Centola; Randle M Gallucci; Ricardo Saban
Journal:  BMC Immunol       Date:  2007-05-16       Impact factor: 3.615

5.  Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-alpha.

Authors:  Marcia R Saban; Michael A O'Donnell; Robert E Hurst; Xue-Ru Wu; Cindy Simpson; Igor Dozmorov; Carole Davis; Ricardo Saban
Journal:  BMC Immunol       Date:  2008-02-11       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.